Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biomark Diagnostics Inc (BMKDF)

Biomark Diagnostics Inc (BMKDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology Newsfile - Thu Jan 15, 7:36AM CST

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic CapabilitiesVancouver, British Columbia--(Newsfile Corp. - January...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark: 2025 Achievements & 2026 Vision Newsfile - Wed Dec 31, 2025

Celebrating A Year of Extraordinary AchievementVancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"),...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors Newsfile - Tue Dec 30, 2025

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: BUX)...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program Newsfile - Tue Dec 23, 2025

Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE:...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala Newsfile - Mon Dec 1, 2025

Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening PlatformVancouver, British Columbia--(Newsfile Corp. - December 1,...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy Newsfile - Wed Nov 12, 2025

Next-generation metabolomics and AI technology supports the 2026 - 2035 Pan-Canadian Lung Cancer Action Plan's call to expand equitable access to life-saving early diagnosisVancouver, British Columbia--(Newsfile...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial Newsfile - Tue Oct 7, 2025

Extensive Validation of BioMark's Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.Vancouver,...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy Newsfile - Mon Sep 29, 2025

Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets.Vancouver, British Columbia--(Newsfile Corp. -...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership Newsfile - Tue Aug 12, 2025

Proof-of-Concept Trial Opens Door to 90+ Million Population Across North Africa and Francophone MarketsVancouver, British Columbia--(Newsfile Corp. - August 12, 2025) - BioMark Diagnostics Inc. (CSE:...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships Newsfile - Tue Aug 5, 2025

Expansion of BioMark brings advanced equipment and doubles capacity, accelerating commercialization of lung cancer assayVancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - BioMark Diagnostics...

BUX.CN : 0.5500 (-1.79%)
BMKDF : 0.3774 (-6.47%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot